Breaking News
Get 45% Off 0
🔎 How to spot overhyped stocks (like these) before they drop
Read more

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Drug/Biotech Stock Earnings on Feb 2: AMGN, PFE & CTLT By Zacks Investment Research - Jan 31, 2021

A few large pharma companies have already reported their fourth-quarter results. Johnson & Johnson JNJ and Eli Lilly (NYSE:LLY) surpassed estimates for both earnings and sales in the fourth...

Can Biogen (BIIB) Keep the Earnings Streak Alive in Q4? By Zacks Investment Research - Jan 31, 2021

We expect Biogen, Inc. BIIB to beat expectations when it reports fourth-quarter and full-year 2020 results on Feb 3, before market open. In the last reported quarter, the company delivered an earnings...

Why Lumentum (LITE) Might Surprise This Earnings Season By Zacks Investment Research - Jan 31, 2021 1

Investors are always looking for stocks that are poised to beat at earnings season and Lumentum Holdings (NASDAQ:LITE) Inc. LITE may be one such company. The firm has earnings coming up pretty soon,...

Stocks Plunge Over 3% in Final Week of January By Zacks Investment Research - Jan 29, 2021

Stocks had their second significant selloff of the past three sessions on Friday, leading to steep weekly losses for all three major indices as we close out the first month of 2021 with a whimper. ...

Stocks Plunge Over 3% in Final Week of January By Zacks Investment Research - Jan 29, 2021

Stocks had their second significant selloff of the past three sessions on Friday, leading to steep weekly losses for all three major indices as we close out the first month of 2021 with a whimper. ...

Stocks Plunge Over 3% in Final Week of January By Zacks Investment Research - Jan 29, 2021

Stocks had their second significant selloff of the past three sessions on Friday, leading to steep weekly losses for all three major indices as we close out the first month of 2021 with a whimper. ...

Heritage Commerce (HTBK) Matches Q4 Earnings Estimates By Zacks Investment Research - Jan 29, 2021

Heritage Commerce (NASDAQ:HTBK) came out with quarterly earnings of $0.19 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.27 per share a year ago. These figures...

5 Top-Rated Stocks With Impressive Net Profit Margins By Zacks Investment Research - Jan 29, 2021

Net profit, also referred to as the bottom line, is one of the key tools that determines the financial health of an enterprise. The metric demonstrates a company’s ability to convert per dollar...

Buy Shopify Stock on the Dip Heading into Q4 Earnings? By Zacks Investment Research - Jan 29, 2021

Shopify (NYSE:SHOP) SHOP was one was of the stars as the market surged off its March lows last year, alongside Zoom ZM and others that benefitted from the coronavirus conditions. The stock has soared...

Is a Beat in Store for Suncor (SU) This Earnings Season? By Zacks Investment Research - Jan 29, 2021

Suncor Energy (NYSE:SU) SU is set to release fourth-quarter 2020 results on Wednesday, Feb 3. The current Zacks Consensus Estimate for the to-be-reported quarter is a loss of 12 cents per share on...

ExxonMobil (XOM) to Report Q4 Earnings: A Beat in the Cards? By Zacks Investment Research - Jan 29, 2021

Exxon Mobil Corporation (NYSE:XOM) XOM is expected to beat fourth-quarter 2020 earnings estimates when it reports results on Feb 2, before the opening bell.In the last reported quarter, the leading...

3 Blue Chip Tech Stocks to Buy Now After Strong Earnings By Zacks Investment Research - Jan 29, 2021

The market went on a wild ride during the last week of January. The week began with the S&P 500 and the Nasdaq jumping to new records. Stocks then tumbled on Wednesday, in a move that was likely...

NVR Q4 Earnings & Revenues Top Estimates, Backlogs Up 40% By Zacks Investment Research - Jan 29, 2021

NVR (NYSE:NVR), Inc. NVR reported better-than-expected fourth-quarter 2020 results. Earnings not only beat the estimates for the second straight quarter, but also improved year over year. Results...

Will Housing ETFs Gain on Soaring Existing Home Sales? By Zacks Investment Research - Jan 29, 2021

The latest existing home sales data has pleased investors. Notably, the pandemic-hit 2020 saw existing home sales reach the highest level since before the Great Recession. This was highlighted in the...

Colgate's (CL) Q4 Earnings In Line, Sales Beat Estimates By Zacks Investment Research - Jan 29, 2021

Colgate-Palmolive Company (NYSE:CL) CL has reported fourth-quarter 2020 results, wherein earnings came in-line with Zacks Consensus Estimate, while sales surpassed the same. Moreover, both top and...

Continue with Apple
Continue with Google
or
Sign up with Email